These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 10447454

  • 1. Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice.
    Chia LG, Ni DR, Cheng FC, Ho YP, Kuo JS.
    Neurochem Res; 1999 Jun; 24(6):719-22. PubMed ID: 10447454
    [Abstract] [Full Text] [Related]

  • 2. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 5,7-dihydroxytryptamine on the locomotor activity and striatal amines in C57BL/6 mice.
    Chia LG, Ni DR, Cheng LJ, Kuo JS, Cheng FC, Dryhurst G.
    Neurosci Lett; 1996 Oct 25; 218(1):67-71. PubMed ID: 8939482
    [Abstract] [Full Text] [Related]

  • 3. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
    Melamed E, Pikarski E, Goldberg A, Rosenthal J, Uzzan A, Conforti N.
    Brain Res; 1986 Dec 03; 399(1):178-80. PubMed ID: 3492237
    [Abstract] [Full Text] [Related]

  • 4. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM, Murphy DL.
    J Neurochem; 1993 Mar 03; 60(3):1167-70. PubMed ID: 8094744
    [Abstract] [Full Text] [Related]

  • 5. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
    Sheng JG.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug 03; 22(4):213-5, 253. PubMed ID: 2575971
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT, Snodgrass SR.
    Brain Res; 1978 Sep 08; 152(3):555-66. PubMed ID: 308384
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T, Satoh N, Sakuma I, Matsumura T, Kisara K, Arai Y, Kinemuchi H.
    Life Sci; 1987 Mar 30; 40(13):1309-18. PubMed ID: 2436017
    [Abstract] [Full Text] [Related]

  • 8. Increase of striatal dopamine turnover by stress in MPTP-treated mice.
    Urakami K, Masaki N, Shimoda K, Nishikawa S, Takahashi K.
    Clin Neuropharmacol; 1988 Aug 30; 11(4):360-8. PubMed ID: 3264755
    [Abstract] [Full Text] [Related]

  • 9. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
    Spooren WP, Vassout A, Waldmeier P, Gentsch C.
    Eur J Pharmacol; 1998 Jul 17; 353(1):1-4. PubMed ID: 9721033
    [Abstract] [Full Text] [Related]

  • 10. Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice.
    Fredriksson A, Fredriksson M, Eriksson P.
    Toxicol Appl Pharmacol; 1993 Oct 17; 122(2):258-64. PubMed ID: 8212007
    [Abstract] [Full Text] [Related]

  • 11. Proposed animal model of attention deficit hyperactivity disorder.
    Kostrzewa RM, Brus R, Kalbfleisch JH, Perry KW, Fuller RW.
    Brain Res Bull; 1994 Oct 17; 34(2):161-7. PubMed ID: 7913871
    [Abstract] [Full Text] [Related]

  • 12. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.
    Fornai F, Bassi L, Torracca MT, Scalori V, Corsini GU.
    Eur J Pharmacol; 1995 Sep 05; 283(1-3):99-102. PubMed ID: 7498327
    [Abstract] [Full Text] [Related]

  • 13. Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.
    Miville-Godbout E, Bourque M, Morissette M, Al-Sweidi S, Smith T, Mochizuki A, Senanayake V, Jayasinghe D, Wang L, Goodenowe D, Di Paolo T.
    PLoS One; 2016 Sep 05; 11(3):e0151020. PubMed ID: 26959819
    [Abstract] [Full Text] [Related]

  • 14. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches.
    Hara K, Tohyama I, Kimura H, Fukuda H, Nakamura S, Kameyama M.
    Brain Res; 1987 May 05; 410(2):371-4. PubMed ID: 3297254
    [Abstract] [Full Text] [Related]

  • 15. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 16. Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice.
    Gao ZG, Cui WY, Zhang HT, Liu CG.
    Pharmacol Res; 1998 Aug 05; 38(2):101-6. PubMed ID: 9721596
    [Abstract] [Full Text] [Related]

  • 17. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R, Sindhu KM, Chandra G, Mohanakumar KP.
    Behav Brain Res; 2005 Sep 08; 163(2):159-67. PubMed ID: 15941598
    [Abstract] [Full Text] [Related]

  • 18. Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.
    Datta I, Mekha SR, Kaushal A, Ganapathy K, Razdan R.
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb 08; 393(2):147-165. PubMed ID: 31468077
    [Abstract] [Full Text] [Related]

  • 19. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice.
    Tabatabaei A, Perry TL, Hansen S, Krieger C.
    Neurosci Lett; 1992 Jul 20; 141(2):192-4. PubMed ID: 1436633
    [Abstract] [Full Text] [Related]

  • 20. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y.
    Neurosci Res; 2005 Mar 20; 51(3):265-74. PubMed ID: 15710490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.